Muscle mass on CT scans and IBD treatment outcomes
Part of Bones, joints & muscles, Digestive system clinical trials.
This study uses CT scans to look at muscle quantity and quality in people with IBD who are on biologic therapy. The goal is to see if low muscle mass (sarcopenia) is linked to how well the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis.
- You must have received biologic therapy (a type of medication that targets specific parts of the immune system).
- You cannot be pregnant.
- You cannot have had your colon (large intestine) removed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at muscle strength and muscle mass in people with inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis. It aims to understand how IBD affects muscles, which can help improve patient care.
This study looks at how common muscle loss (sarcopenia) is in people with inflammatory bowel disease during a flare-up, and what impact it has. By participating, you may help doctors better understand and treat muscle weakness in IBD.
This study looks at how nutrition affects people with IBD who are starting a new treatment or having surgery. Researchers want to find out if diet or body changes influence how well you recover.
This study looks at how muscle loss (sarcopenia) affects people diagnosed with colorectal cancer before age 50. It uses CT or MRI scans taken at diagnosis to measure muscle mass and see how it relates to treatment and outcomes.
This study looks at how loss of muscle mass (sarcopenia) affects the course of illness in people with gastrointestinal cancers, liver cirrhosis, or those in the ICU. It will help doctors better understand and treat muscle wasting.
This study looks at how muscle loss (sarcopenia) might affect side effects from cancer treatments. If you are starting a new cancer treatment, a CT scan before treatment can help doctors predict your risk of side effects.
Hear when a new CT-Assessed Sarcopenia Outcomes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.